Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

172.21
Delayed Data
As of 3:59pm ET
 +2.73 / +1.61%
Today’s Change
127.10
Today|||52-Week Range
213.27
-10.28%
Year-to-Date
Illumina Keen on Genome Network Growth & Global Expansion
4:02pm / Zacks.com - Paid Partner Content
3 Top Stocks You Can Buy and Hold for the Next Decade
Aug 23 / MotleyFool.com - Paid Partner Content
Stock Market News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
Illumina Rallies on Rumors of Takeover by Thermo Fisher
Aug 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close169.48
Today’s open170.38
Day’s range170.01 - 174.01
Volume820,145
Average volume (3 months)1,284,011
Market cap$24.8B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+6.33%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+19.25%
P/E ratio59.0
Price/Sales12.89
Price/Book13.44

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.08+0.17%
NBIXNeurocrine Bioscienc...+0.60+1.23%
TECHBio-Techne Corp+0.59+0.56%
JUNOJuno Therapeutics In...+0.69+2.19%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Senior Vice President-Global Quality &
Operations
Robert P. Ragusa
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs